13th ASM Conference on Candida and Candidiasis

第 13 届 ASM 念珠菌和念珠菌病会议

基本信息

批准号：
9053214
负责人：
Theodore C. White
金额：
$ 0.8万
依托单位：
AMERICAN SOCIETY FOR MICROBIOLOGY
依托单位国家：
美国
项目类别：
财政年份：
2016
资助国家：
美国
起止时间：
2016-02-15 至 2017-01-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9053214
关键词：
AIDS/HIV problem Achievement Acquired Immunodeficiency Syndrome Address Affect Agreement American Antifungal Agents Area Azoles Biological Candida Candida albicans Candida glabrata Candidiasis Case Study Cell Communication Chemotherapy-Oncologic Procedure Clinical Collaborations Communicable Diseases Communities Community Developments Development Diagnosis Disease Disseminated candidiasis Drug Interactions Drug resistance Educational workshop Elevator Epidemiology Esophageal Failure Feedback Filler Financial Support Frequencies Funding Fungal Drug Resistance Genes Genomics Goals Growth Guidelines Healthcare Host Defense Human Imagination Immune Immune response Immunocompetent Immunocompromised Host Immunology Individual Infection International Lead Life Medical Metabolic Microbial Biofilms Microbiology Minority Modeling Molecular Names Neonatal Intensive Care Units Oral candidiasis Oropharyngeal Participant Partner in relationship Pathogenicity Patients Premature Infant Prophylactic treatment Proteomics Publications Recording of previous events Research Research Personnel Resources Role San Francisco Scientist Series Signal Transduction Societies Staging Surveys System Systems Biology Techniques Technology The science of Mycology Therapeutic Time Training Woman abstracting base candidemia career flexibility fungus genome annotation genome sequencing in vivo interest meetings mutant new technology pathogen posters prevent programs public health relevance resistance mechanism response screening success symposium tool transcriptomics vaginal candidiasis

项目摘要

DESCRIPTION (provided by the applicant): Candida is the major fungal pathogen of humans, causing diseases that range from oral and vaginal candidiasis to life-threatening candidemia and invasive disease. The Candida research community focuses on a broad spectrum of subjects that relate to epidemiology, drug resistance, infection, host response, and therapeutics. The biennial Candida and Candidiasis Conference is the premier forum for presentation of cutting-edge advances and the latest perspectives in these diverse areas. Funds are requested for partial support for the 13th Conference on Candida and Candidiasis, to be held April 13 - 17, 2016, in Seattle, WA. The conference is sponsored in part by the American Society for Microbiology, which provides both management expertise and financial support. The Program is based upon past conferences, which reliably draw approximately 400 U.S. and International scientists, and have been met with enthusiastic support in participant surveys. The Program includes 17 sessions, with 5 or 6 speakers in each section. At least 68 of the talks will be selected based on submitted abstracts. Chairs for each session have been selected for their expertise in the subject area. This arrangement provides flexibility to present cutting-edge advances and to enlist a diverse spectrum of emerging and established speakers. Parallel sessions will address infection models, metabolic adaptation, fungal drug interactions and new technologies while encouraging productive interaction and discussion. "Elevator talks" will allow junior scientists to summarize their poster in a few minutes on stage. Three afternoon poster sessions will allow discussion of the 250-350 posters. Clinical talks about the epidemiology, diagnosis, and treatment of candidiasis will be incorporated into sessions that focus on key aspects of Candida infections, including environmental signaling, antifungal agents and resistance, and immune recognition. In a separate session on Candida case reports, clinicians will inform basic scientists about the challenges of diagnosing and treating different types of infection. We are confident that we will achieve our meeting goals - to present the latest advances in the field, to spotlight achievements of junior scientists (especially women and minorities), to promote synergistic and interdisciplinary interactions, and to provide a venue for community-wide discussion.

描述（由适用提供）：念珠菌是人类的主要真菌病原体，导致疾病的疾病从口腔和阴道念珠菌病到威胁生命的念珠菌和入侵性疾病。念珠菌研究界的重点是与流行病学，耐药性，感染，宿主反应和治疗相关的广泛受试者。两年一次的念珠菌和念珠菌会议是介绍前沿进步和这些潜水区最新观点的首要论坛。要求资金在2016年4月13日至17日在华盛顿州西雅图举行的第13届念珠菌和念珠菌病。该会议由美国微生物学会的部分赞助，该学会提供了管理专业知识和财务支持。该计划基于过去的会议，该会议可靠地吸引了大约400名美国和国际科学家，并得到了参与调查的热情支持。该计划包括17个会议，每个部分中有5或6个发言人。至少有68个会谈将根据提交的摘要选择。每个会议的椅子都被选为其在学科领域的专业知识。这种安排为目前的进步提供了灵活性，并吸引了新兴和成熟的演讲者的潜水者。并行会议将介绍感染模型，代谢适应性，真菌药物相互作用和新技术，同时鼓励产品互动和讨论。 “电梯谈话”将使初级科学家在舞台上几分钟内总结他们的海报。三个下午的海报会议将允许讨论250-350海报。关于念珠菌病的流行病学，诊断和治疗的临床讨论将被纳入会议中，这些会议重点是念珠菌感染的关键方面，包括环境信号，抗真菌药物和抗药性和耐药性以及免疫识别。在关于念珠菌病例报告的另一项会议中，临床医生将向基础科学家告知诊断的挑战和治疗不同类型的感染。我们有信心我们将实现我们的会议目标 - 介绍该领域的最新进展，以聚焦初级科学家（尤其是妇女和少数民族）的成就，以促进协同和跨学科的互动，并为社区范围内的讨论提供场地。